What is Bevacizumab-tnjn: Uses, Dosage, Side Effects and More

Bevacizumab-tnjn is a targeted cancer therapy that helps slow tumor growth by blocking blood vessel formation. This medication belongs to a class of drugs called monoclonal antibodies, which work like guided missiles to find and attack specific proteins that cancer cells need to survive and spread.

You might feel overwhelmed learning about this treatment, and that's completely natural. Understanding how your medication works can help you feel more confident about your treatment plan and what to expect along the way.

What is Bevacizumab-tnjn?

Bevacizumab-tnjn is a biosimilar version of the original bevacizumab medication. A biosimilar means it's highly similar to the original drug in terms of safety and effectiveness, but it's made by a different manufacturer using slightly different processes.

This medication is a laboratory-made antibody that mimics your body's natural immune system. It specifically targets a protein called VEGF (vascular endothelial growth factor), which tumors use to create new blood vessels. By blocking this protein, the medication can help starve tumors of the nutrients they need to grow.

The "-tnjn" part of the name is simply a suffix that helps distinguish this particular biosimilar from others. Think of it like a last name that helps identify which specific version of the medication you're receiving.

What is Bevacizumab-tnjn Used For?

Bevacizumab-tnjn treats several types of cancer by targeting the blood supply that feeds tumors. Your doctor has prescribed this medication because it can help slow down cancer growth and may shrink existing tumors.

The medication is commonly used for these specific cancer types:

• Colorectal cancer (cancer of the colon or rectum)
• Lung cancer, particularly non-small cell lung cancer
• Kidney cancer (renal cell carcinoma)
• Cervical cancer
• Ovarian cancer
• Glioblastoma (a type of brain tumor)

Your oncologist will often combine bevacizumab-tnjn with other cancer treatments like chemotherapy. This combination approach can be more effective than using any single treatment alone, giving you the best possible chance for a positive outcome.

How Does Bevacizumab-tnjn Work?

Bevacizumab-tnjn works by cutting off the blood supply that tumors need to grow and spread. This makes it a moderately strong medication that can significantly impact cancer progression when used appropriately.

Here's how the process works in simple terms. Cancer cells release a protein called VEGF, which signals your body to create new blood vessels around the tumor. These new blood vessels act like highways, delivering oxygen and nutrients that help the cancer grow and spread to other parts of your body.

Bevacizumab-tnjn blocks VEGF from sending these signals. When the medication binds to VEGF, it prevents new blood vessels from forming around the tumor. Without this blood supply, the tumor struggles to get the nutrients it needs to continue growing.

This process is called anti-angiogenesis, which literally means "against blood vessel formation." While this approach doesn't directly kill cancer cells like chemotherapy does, it can effectively slow down cancer growth and make other treatments more effective.

How Should I Take Bevacizumab-tnjn?

Bevacizumab-tnjn is given as an intravenous (IV) infusion directly into your bloodstream at a cancer treatment center or hospital. You cannot take this medication as a pill or inject it yourself at home.

Your healthcare team will insert a small tube (IV line) into a vein in your arm or use a central line if you have one. The medication is mixed with a saline solution and slowly dripped into your bloodstream over 30 to 90 minutes. Your first infusion typically takes longer as your medical team monitors how you respond to the treatment.

You don't need to take this medication with food or avoid eating beforehand. However, it's helpful to stay well-hydrated by drinking plenty of water before and after your treatment. Some people find it comforting to bring a snack, book, or tablet to help pass the time during the infusion.

Your treatment schedule will depend on your specific cancer type and overall treatment plan. Most people receive infusions every 2 to 3 weeks, but your oncologist will determine the exact timing that's right for your situation.

How Long Should I Take Bevacizumab-tnjn For?

The length of your bevacizumab-tnjn treatment depends on how well your cancer responds and how your body tolerates the medication. Most people continue treatment for several months, though some may need it for a year or longer.

Your oncologist will regularly monitor your progress through blood tests, imaging scans, and physical examinations. These checkups help determine whether the medication is working effectively and whether you're experiencing any concerning side effects.

Treatment typically continues as long as your cancer remains stable or improves and you're not experiencing severe side effects. Your doctor might recommend stopping the medication if scans show your cancer is progressing despite treatment, or if side effects become too difficult to manage.

It's important to attend all your scheduled appointments and never stop treatment on your own. If you're having concerns about continuing treatment, discuss them openly with your healthcare team. They can help adjust your treatment plan or provide additional support to help you through challenging periods.

What Are the Side Effects of Bevacizumab-tnjn?

Bevacizumab-tnjn can cause side effects because it affects blood vessel formation throughout your body, not just around tumors. Most people experience some side effects, but many are manageable with proper care and monitoring.

The most common side effects that many people experience include:

• High blood pressure (hypertension)
• Fatigue and weakness
• Diarrhea
• Decreased appetite
• Headaches
• Nausea
• Protein in urine
• Nosebleeds
• Changes in taste

Your healthcare team will monitor your blood pressure closely and may prescribe medication to keep it under control. They'll also check your urine regularly to watch for protein, which can indicate kidney effects from the treatment.

Some serious side effects require immediate medical attention, though they're less common. These include severe bleeding, blood clots, heart problems, and delayed wound healing. Your medical team will discuss these risks with you and explain warning signs to watch for.

Rare but serious complications can include bowel perforation (a hole in the intestinal wall), severe high blood pressure, or problems with wound healing after surgery. While these sound frightening, your healthcare team is experienced in managing these risks and will monitor you carefully throughout treatment.

Who Should Not Take Bevacizumab-tnjn?

Bevacizumab-tnjn isn't safe for everyone, and your doctor will carefully review your medical history before prescribing it. Certain health conditions or situations make this medication too risky to use.

You should not receive bevacizumab-tnjn if you have any of these conditions:

• Recent major surgery (within the past 28 days)
• Serious bleeding problems or bleeding disorders
• Untreated brain metastases
• Severe heart failure
• Recent heart attack or stroke
• Pregnancy or breastfeeding
• Severe kidney disease

Your doctor will also be cautious about prescribing this medication if you have high blood pressure that's difficult to control, a history of blood clots, or if you're planning to have surgery soon. These conditions don't automatically rule out treatment, but they require extra monitoring and precautions.

If you're pregnant or could become pregnant, it's crucial to discuss birth control options with your healthcare team. Bevacizumab-tnjn can cause serious birth defects, so effective contraception is essential during treatment and for several months afterward.

Bevacizumab-tnjn Brand Names

Bevacizumab-tnjn is sold under the brand name Mvasi in the United States. This is the biosimilar version of the original bevacizumab medication, which is sold under the brand name Avastin.

Both medications work essentially the same way and have similar effectiveness and safety profiles. The main difference is that Mvasi is typically less expensive than Avastin, which can help reduce treatment costs.

Your insurance plan or treatment center may prefer one version over the other based on cost or availability. You can feel confident that both versions have undergone rigorous testing to ensure they're safe and effective for cancer treatment.

Bevacizumab-tnjn Alternatives

Several other medications work similarly to bevacizumab-tnjn by targeting blood vessel formation around tumors. Your oncologist might consider these alternatives if bevacizumab-tnjn isn't suitable for your situation.

Other anti-angiogenesis medications include:

• Ramucirumab (Cyramza) - used for stomach, lung, and liver cancers
• Aflibercept (Zaltrap) - used for colorectal cancer
• Sorafenib (Nexavar) - used for kidney and liver cancers
• Sunitinib (Sutent) - used for kidney cancer and certain stomach tumors

Each of these medications has different side effect profiles and is approved for different types of cancer. Your oncologist will choose the best option based on your specific cancer type, overall health, and how well you've responded to previous treatments.

The choice between these medications often depends on factors like your kidney function, blood pressure, and risk of bleeding. Your healthcare team will work with you to find the treatment that offers the best balance of effectiveness and manageable side effects.

Is Bevacizumab-tnjn Better Than Avastin?

Bevacizumab-tnjn (Mvasi) and Avastin are considered equally effective for treating cancer. Both medications contain the same active ingredient and work in exactly the same way to block blood vessel formation around tumors.

The FDA has determined that bevacizumab-tnjn is a biosimilar to Avastin, meaning it has no clinically meaningful differences in safety or effectiveness. Studies have shown that people who receive either medication have similar outcomes and side effect profiles.

The main advantage of bevacizumab-tnjn is cost. As a biosimilar, it's typically less expensive than the original Avastin, which can significantly reduce treatment costs for both patients and healthcare systems.

Your choice between these medications will likely depend on factors like insurance coverage, hospital formulary preferences, and availability. You can feel confident that both options will provide the same cancer-fighting benefits.